(Jerusalem Post) Sharon Udasin - The Israel-U.S. Binational Industrial Research and Development Foundation (BIRD) will invest $7 million in eight new Israeli-American ventures involving autonomous vehicles, biotechnology, digital health, homeland security and nanotechnology, the foundation announced Wednesday. The projects include Israel's Atvio and the Telford, Pa.-based Secant Group, which will be creating a three-dimensional culture platform of therapeutic cells manufactured using biomaterials. Israel's Check-Cap and Marlborough, Mass.- based GE Healthcare will be developing a new colon cancer screening system for high volume manufacture. Nutrino Health and Denver, Colo.-based Welltok will be establishing personalized nutrition recommendations for employers and health plans, while Pill Tracker and New York-based Target Health will be working on a mechanism for medication tracking and drug compliance. Over its 40-year history, BIRD has invested more than $340 million in joint projects, yielding more than $10 billion in direct and indirect revenue.
2017-06-30 00:00:00Full ArticleBACK Visit the Daily Alert Archive